Axios on MSN6h
Use of diabetes and anti-obesity drugs surges nationwideAxios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback